person · Reporting owner
DIGIANDOMENICO ANTHONY
Disclosed activity across 7 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ClearSign Technologies CorpCLIR · Entity 7487 | Director | September 30, 2026 | October 02, 2026 |
| Cue Biopharma, Inc.CUE · Entity 6301 | Director | December 24, 2018 | January 04, 2019 |
| ENDRA Life Sciences Inc.NDRA · Entity 8083 | Director | January 21, 2026 | January 24, 2026 |
| EXOZYMES INC.IZTC · Entity 1147 | Director · 10% owner | November 08, 2024 | November 19, 2024 |
| Illumination Acquisition Corp. IILLU · Entity 5913 | Director | February 26, 2026 | February 26, 2026 |
| MDB Capital Holdings, LLCMDBH · Entity 7469 | Director · 10% owner | April 28, 2025 | August 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ClearSign Technologies Corp
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Statutory Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.55 · Expires 2036-09-29 | Direct | 3,766 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 3,766 · Balance 3,766 F1: As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date.
Cue Biopharma, Inc.
Report date December 24, 2018 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2018-12-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-12-24 · Purchase · Acquired 10,000 · Balance 30,000 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.94, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2: Shares are held jointly with the reporting person's spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.94, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4
F2: Shares are held jointly with the reporting person's spouse.
ENDRA Life Sciences Inc.
Report date January 21, 2026 · Filed January 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 136,589 |
Reported balance
After 2026-01-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 60,324 · Balance 136,589 F1: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. F2: Includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027.
F2: Includes unvested RSUs.
EXOZYMES INC.
Report date November 08, 2024 · Filed November 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,808,476 |
Reported balance
Holding disclosure · report date 2024-11-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,808,476 F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| SAFE for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.40 · Expires 2024-11-30 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2025-06-22 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $2.44, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Stock Options for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2028-01-31 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter and are fully vested on January 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $2.44, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC.
F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter and are fully vested on January 31, 2026.
Illumination Acquisition Corp. I
Report date February 26, 2026 · Filed February 26, 2026
This filing explicitly reported no securities owned.
MDB Capital Holdings, LLC
Report date April 28, 2025 · Filed August 08, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-04-28 | Direct | 0 |
Reported balance
After 2025-04-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-04-28 · Disposition to issuer · Disposed 900,000 · Balance 0 |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.25 · Expires 2035-04-28 | Direct | 900,000 |
Reported balance
After 2025-04-28 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2025-04-28 · Grant · Acquired 900,000 · Balance 900,000 F1: 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027. F2: 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share. |
Filing footnotes · ownership attribution and instrument terms
F1: 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027.
F2: 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Provention Bio, Inc.
Report date May 15, 2020 · Filed June 17, 2020
Section 16 reporting ended · disclosed 2020-06-17. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 23:00 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantNon-Statutory Stock Options · Derivative | 3,766 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001104659-26-113412 · tm2626853-1_4seq1.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,766 Underlying: Common Stock · 3,766 shares Expires 2036-09-29 F1 · derivative.exercise_date: As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:00 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantNon-Statutory Stock Options · Derivative | 4,595 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001104659-26-080466 · tm2619589-1_4seq1.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 Underlying: Common Stock · 4,595 shares Expires 2036-06-29 F1 · derivative.exercise_date: As compensation for services as a non-employee director during the quarter ended June 30, 2026, the reporting person was granted non-statutory stock options to purchase 4,595 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 23:00 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantNon-Statutory Stock Options · Derivative | 3,024 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001104659-26-039309 · tm2610943-1_4seq1.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,024 Underlying: Common Stock · 3,024 shares Expires 2036-03-31 F1 · derivative.exercise_date: As compensation for services as a non-employee director during the quarter ended March 31, 2026, the reporting person was granted non-statutory stock options to purchase 3,024 shares of common stock under the ClearSign Technologies Corporation 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 00:44 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantCommon Stock | 60,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021415 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,589 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:54 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantWarrants · Derivative | 141,644 | $7.06 Strike: $6.81 | $1,000,006.64 |
DisclosureSEC source: 0001193125-25-240662 · ownership.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,644 Underlying: Common Stock · 141,644 shares Expires 2030-10-15 F1 · kind: The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:54 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantCommon Stock | 70,822 | $7.06 | $500,003.32 |
DisclosureSEC source: 0001193125-25-240662 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,265 F1 · kind: The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock. F3 · balance_after: Includes unvested restricted stock units. Read SEC document |
| June 11, 2025 Filed Jul 1, 2025 10:25 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantCommon Stock | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091885 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,443 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 01:01 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | GrantEmployee Stock Option · Derivative | 900,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001641172-25-006734 · ownership.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Class A · 900,000 shares Expires 2035-04-28 F1 · security: 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027. F2 · security: 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 01:01 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Disposition to issuerRSU · Derivative | 900,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-006734 · ownership.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A · 900,000 shares Expires 2025-04-28 Read SEC document |
| April 28, 2025 Filed Aug 8, 2025 23:18 UTC Amendment | MDB Capital Holdings, LLC MDBH · Entity 7469 | GrantEmployee Stock Option · Derivative | 900,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001641172-25-022846 · ownership.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Class A · 900,000 shares Expires 2035-04-28 F1 · security: 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027. F2 · security: 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share. Read SEC document |
| April 28, 2025 Filed Aug 8, 2025 23:18 UTC Amendment | MDB Capital Holdings, LLC MDBH · Entity 7469 | Disposition to issuerRSU · Derivative | 900,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-022846 · ownership.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A · 900,000 shares Expires 2025-04-28 Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 22:21 UTC | MDB Capital Holdings, LLC MDBH? · Entity 7469 | PurchaseCommon Stock | 1,425 | $4.90 | $6,982.50 |
DisclosureSEC source: 0001641172-25-003465 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,699 Read SEC document |
| April 07, 2025 Filed Aug 8, 2025 23:09 UTC Amendment | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,425 | $4.90 | $6,982.50 |
DisclosureSEC source: 0001641172-25-022844 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,699 Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:21 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 942 | $6.15 | $5,793.30 |
DisclosureSEC source: 0001493152-25-007022 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,274 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 13, 2025 were purchased in multiple transactions at prices ranging from $6.10 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2025 Filed Feb 15, 2025 00:21 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 290 | $6.15 | $1,783.50 |
DisclosureSEC source: 0001493152-25-007022 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,332 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 12, 2025 were purchased in multiple transactions at prices ranging from $6.13 to $6.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2025 Filed Feb 11, 2025 23:48 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.22 | $6,220.00 |
DisclosureSEC source: 0001493152-25-005974 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,042 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 11, 2025 were purchased in multiple transactions at prices ranging from $6.21 to $6.24 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:48 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.22 | $6,220.00 |
DisclosureSEC source: 0001493152-25-005974 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,042 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 7, 2025 were purchased in multiple transactions at prices ranging from $6.21 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 21:50 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 300 | $6.24 | $1,872.00 |
DisclosureSEC source: 0001493152-25-005217 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,042 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 5, 2025 were purchased in multiple transactions at prices ranging from $6.23 to $6.24 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:50 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 398 | $6.22 | $2,475.56 |
DisclosureSEC source: 0001493152-25-005217 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,742 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 4, 2025 were purchased in multiple transactions at prices ranging from $6.15 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2025 Filed Feb 3, 2025 22:23 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.17 | $6,170.00 |
DisclosureSEC source: 0001493152-25-004705 · ownership.xml · nonDerivative · entry 3 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,344 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on February 3, 2025 were purchased in multiple transactions at prices ranging from $6.12 to $6.17 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:23 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.20 | $6,200.00 |
DisclosureSEC source: 0001493152-25-004705 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,344 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 31, 2025 were purchased in multiple transactions at prices ranging from $6.19 to $6.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 22:23 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 100 | $6.22 | $622.00 |
DisclosureSEC source: 0001493152-25-004705 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,344 Read SEC document |
| January 29, 2025 Filed Jan 29, 2025 23:16 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 14 | $6.21 | $86.94 |
DisclosureSEC source: 0001493152-25-004196 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,244 Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 23:16 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 933 | $6.21 | $5,793.93 |
DisclosureSEC source: 0001493152-25-004196 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,230 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 27, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.21 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 20:38 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 164 | $6.21 | $1,018.44 |
DisclosureSEC source: 0001493152-25-003772 · ownership.xml · nonDerivative · entry 3 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,297 F3 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 24, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 20:38 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 200 | $6.24 | $1,248.00 |
DisclosureSEC source: 0001493152-25-003772 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,133 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 23, 2025 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 27, 2025 20:38 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 928 | $6.21 | $5,762.88 |
DisclosureSEC source: 0001493152-25-003772 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,933 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 22, 2025 were purchased in multiple transactions at prices ranging from $6.15 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 02:40 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.21 | $6,210.00 |
DisclosureSEC source: 0001493152-25-003127 · ownership.xml · nonDerivative · entry 3 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,005 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 21, 2025 were purchased in multiple transactions at prices ranging from $6.13 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 02:40 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.10 | $6,100.00 |
DisclosureSEC source: 0001493152-25-003127 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,005 Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:40 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 900 | $6.23 | $5,607.00 |
DisclosureSEC source: 0001493152-25-003127 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,005 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 16, 2025 were purchased in multiple transactions at prices ranging from $6.18 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 23:28 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.04 | $6,040.00 |
DisclosureSEC source: 0001493152-25-002446 · ownership.xml · nonDerivative · entry 3 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,709 F3 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 15, 2025 were purchased in multiple transactions at prices ranging from $5.93 to $6.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2025 Filed Jan 15, 2025 23:28 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.17 | $6,170.00 |
DisclosureSEC source: 0001493152-25-002446 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82.709 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 14, 2025 were purchased in multiple transactions at prices ranging from $6.08 to $6.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 13, 2025 Filed Jan 15, 2025 23:28 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.23 | $6,230.00 |
DisclosureSEC source: 0001493152-25-002446 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,709 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 13, 2025 were purchased in multiple transactions at prices ranging from $6.10 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 01:20 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 16 | $6.25 | $100.00 |
DisclosureSEC source: 0001493152-25-001272 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,709 Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 23:54 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 355 | $6.25 | $2,218.75 |
DisclosureSEC source: 0001493152-24-051920 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,693 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 20, 2024 were purchased in multiple transactions at prices ranging from $6.21 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2024 Filed Dec 30, 2024 18:23 UTC Amendment | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 355 | $6.25 | $2,218.75 |
DisclosureSEC source: 0001493152-24-052434 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,693 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 20, 2024 were purchased in multiple transactions at prices ranging from $6.21 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.24 | $6,240.00 |
DisclosureSEC source: 0001493152-24-050941 · ownership.xml · nonDerivative · entry 3 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,338 F3 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 19, 2024 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,000 | $6.20 | $6,200.00 |
DisclosureSEC source: 0001493152-24-050941 · ownership.xml · nonDerivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,338 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 18, 2024 were purchased in multiple transactions at prices ranging from $6.12 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,693 | $6.21 | $10,513.53 |
DisclosureSEC source: 0001493152-24-050941 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,338 F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on December 17, 2024 were purchased in multiple transactions at prices ranging from $6.20 to $6.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionRSU · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-050943 · ownership.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Class A · 50,000 shares Expires 2024-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionCommon Stock | 50,000 | $6.81 | $340,500.00 |
DisclosureSEC source: 0001493152-24-050943 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Feb 23, 2024 22:00 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 600 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-24-003901 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2034-01-02 F1 · shares: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:07 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | PurchaseWarrants · Derivative | 41,667 | $0.01 Strike: $1.40 | $416.67 |
DisclosureSEC source: 0001209191-23-026925 · doc4.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Stock · 41,667 shares Expires 2028-05-02 F2 · price: The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering. F3 · derivative.underlying_shares: Represents warrants purchased in the Offering. The warrants were offered and sold at the rate of one warrant to purchase one share for every two shares of common stock purchased in the Offering. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:07 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | PurchaseCommon Stock | 83,333 | $1.20 | $99,999.60 |
DisclosureSEC source: 0001209191-23-026925 · doc4.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,434 F1 · shares: Represents shares purchased in the Registrant's underwritten public offering that closed May 2, 2023 (the "Offering"). F2 · price: The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 9,621 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006049 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,621 Underlying: Common Stock · 9,621 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 109,323 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021621 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,323 Underlying: Common Stock · 109,323 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:06 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-000957 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:15 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 25,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001209191-21-025859 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-04-05 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022. Read SEC document |
| January 04, 2021 Filed Mar 25, 2021 21:00 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001209191-21-023038 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-01-04 F1 · shares: Represents a stock option award granted on January 4, 2021 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 12:00 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | OtherWarrants · Derivative | 100,503 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-20-043430 · doc4.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,503 shares Expires 2024-12-11 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.